Literature DB >> 22752651

Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging.

Andreas Schmid1, Heidi Braumüller, Hans F Wehrl, Martin Röcken, Bernd J Pichler.   

Abstract

PURPOSE: Assessing information on tumor progression in the RIP1-Tag2 mouse in vivo is a great challenge because the tumors form spontaneously throughout the pancreas and are difficult to detect with current imaging modalities. In this study, we focused on non-invasive magnetic resonance imaging, providing information on tumor growth. PROCEDURES: Tissue relaxation times were measured over time and were compared between tumors and healthy pancreatic tissue. The effects of age and body temperature on these relaxation times, possibly influencing image contrast and therefore detection capabilities, were evaluated.
RESULTS: Tumors appeared hyperintense in T2-weighted images when they exceeded 0.8 mm in diameter, and both relaxation times showed significantly higher values in tumors than in the healthy pancreas.
CONCLUSION: Visualization and monitoring of these small tumors in vivo is feasible, even under adverse conditions of permanent gut movement. In the mouse model studied, the relaxation times of tumors differed significantly from healthy pancreatic tissue.

Entities:  

Mesh:

Year:  2013        PMID: 22752651     DOI: 10.1007/s11307-012-0548-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  30 in total

1.  A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesis.

Authors:  Adrian Zumsteg; Karin Strittmatter; Daniela Klewe-Nebenius; Helena Antoniadis; Gerhard Christofori
Journal:  Carcinogenesis       Date:  2010-06-08       Impact factor: 4.944

Review 2.  MR thermometry.

Authors:  Viola Rieke; Kim Butts Pauly
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

Review 3.  Cell tracking with optical imaging.

Authors:  Elizabeth J Sutton; Tobias D Henning; Bernd J Pichler; Christoph Bremer; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2008-05-28       Impact factor: 5.315

4.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

Authors:  Hiroaki Nozawa; Christopher Chiu; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

5.  Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

Authors:  Damian Wild; Andreas Wicki; Rosalba Mansi; Martin Béhé; Boris Keil; Peter Bernhardt; Gerhard Christofori; Peter J Ell; Helmut R Mäcke
Journal:  J Nucl Med       Date:  2010-07       Impact factor: 10.057

6.  Multishot PROPELLER for high-field preclinical MRI.

Authors:  Prachi Pandit; Yi Qi; Jennifer Story; Kevin F King; G Allan Johnson
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

Review 7.  Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data.

Authors:  B Gallwitz
Journal:  Int J Clin Pract       Date:  2006-12       Impact factor: 2.503

8.  68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression.

Authors:  Clemens Decristoforo; Ignacio Hernandez Gonzalez; Janette Carlsen; Marco Rupprich; Marc Huisman; Irene Virgolini; Hans-Jürgen Wester; Roland Haubner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-28       Impact factor: 9.236

9.  Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.

Authors:  Barbara Sennino; Hans-Juergen Raatschen; Michael F Wendland; Yanjun Fu; Weon-Kyoo You; David M Shames; Donald M McDonald; Robert C Brasch
Journal:  Magn Reson Med       Date:  2009-09       Impact factor: 4.668

10.  Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model.

Authors:  Xianhua Cao; Guang Jia; Tao Zhang; Ming Yang; Bing Wang; Peter A Wassenaar; Hao Cheng; Michael V Knopp; Duxin Sun
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-06       Impact factor: 3.333

View more
  3 in total

1.  Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI.

Authors:  Andreas Schmid; Jennifer Schmitz; Julia G Mannheim; Florian C Maier; Kerstin Fuchs; Hans F Wehrl; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

2.  Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a KrasLSL-G12D p53LSL-R172H Pdx1-Cre mouse model.

Authors:  Su Hu; Jia Yang; Junjie Shangguan; Aydin Eresen; Yu Li; Quanhong Ma; Vahid Yaghmai; Yuri Velichko; Chunhong Hu; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

3.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.

Authors:  Sonia A Melo; Linda B Luecke; Christoph Kahlert; Agustin F Fernandez; Seth T Gammon; Judith Kaye; Valerie S LeBleu; Elizabeth A Mittendorf; Juergen Weitz; Nuh Rahbari; Christoph Reissfelder; Christian Pilarsky; Mario F Fraga; David Piwnica-Worms; Raghu Kalluri
Journal:  Nature       Date:  2015-06-24       Impact factor: 69.504

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.